高被引外周动脉疾病研究中作者行业报酬与自报经济利益冲突的比较
该研究比较了2013至2016年高被引外周动脉疾病治疗相关文献中作者自报经济利益冲突(FCOI)与行业报酬数据。在1008名血管专家作者中,218人(22%)自报FCOI,56名医生作者有行业报酬记录,其中28人(50%)自报FCOI。56名作者行业报酬总额为11,139,987美元,中位总报酬为18,827美元(四分位距152,084美元);自报FCOI者的中位总报酬高于未报告者(81,224美元 vs 9494美元,P < .001)。结论认为未披露的行业报酬相对少见但可能金额可观,自报FCOI不能全面反映行业报酬情况。
要点
- 高被引外周动脉疾病研究中仅22%作者自报经济利益冲突,而有行业报酬记录者中仅50%自报。
- 建议报告所有行业报酬而非仅作者认为相关的部分,以提高透明度。
核心结论
- 在高被引外周动脉疾病研究中,作者未披露的行业报酬相对不常见,但可能涉及可观的金额。
- 自报经济利益冲突不能全面反映作者获得的行业报酬情况。
研究设计与样本
- 通过Web of Science检索2013至2016年以「外周动脉疾病」为主题的文献,排除综述、会议论文、书籍章节、摘要及非英文文献。
- 选取被引次数最高的99篇文献,提取作者自报经济利益冲突信息。
- 使用基于CMS Open Payments数据的ProPublica Dollars for Docs自定义数据集查询作者行业报酬,纳入美国心脏病学、心胸外科、血管与介入放射学或血管外科专业的医生作者。
- 根据提供者姓名、专业和地理位置匹配支付记录,进行描述性统计和分类检验。
主要发现
- 共识别1008名血管专家作者,其中218名(22%)自报经济利益冲突。
- 56名医生作者在研究期间有行业报酬记录,其中28名(50%)自报经济利益冲突。
- 56名作者的行业报酬总额为11,139,987美元,中位总报酬为18,827美元(四分位距152,084美元)。
- 食品和饮料是最常见的支付性质(8981笔,74%),推广演讲涉及总金额最大(3,256,431美元),特许权或许可的中位支付额最高(51,431美元,四分位距72,215美元)。
- 自报经济利益冲突的医生获得总报酬9,435,340美元,未报告者为1,706,647美元;自报者中位总报酬为81,224美元(四分位距324,171美元),未报告者为9494美元(四分位距43,448美元),P < .001。
临床怎么用
- 临床医生在解读高被引外周动脉疾病研究时,应意识到自报经济利益冲突可能不完整,需谨慎评估研究的潜在偏倚。
- 建议期刊要求作者报告所有行业报酬而非仅作者认为相关的部分,以便读者独立判断相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Industry compensation to authors may influence the interpretation of study results. Scientific journals often require author disclosure of a relevant financial conflict of interest (FCOI) but seldom quantify compensation and leave reporting up to the author's discretion. Professional and public concerns related to potential bias introduced into medical research by FCOI have arisen, especially when physician compensation from manufacturers is not disclosed. Little is known, however, about the prevalence of industry compensation to authors of related publications, payment amounts, or how this information compares with self-reported FCOI. The objective of this study was to compare industry compensation and disclosed FCOI among highly referenced publications related to treatment of peripheral artery disease, a disease that affects approximately 8.5 million Americans and is often treated with medications and devices. METHODS: "Peripheral artery disease" was used as a Web of Science search term to identify publications from 2013 to 2016, excluding review articles, conference proceedings, book chapters, abstract publications, and non-English language publications. The top 99 most cited publications were abstracted for self-reported FCOI by author. Industry compensation to authors was queried using a ProPublica Dollars for Docs custom data set based on Centers for Medicare and Medicaid Services Open Payments data. Providers practicing in the United States in any of the following specialties were included: cardiology, cardiothoracic surgery, vascular and interventional radiology, or vascular surgery. Payment transactions were matched to physician authors on the basis of provider name, specialty, and geographic location. Statistical analysis included descriptive statistics and categorical tests. Descriptive statistics are reported as frequency (percentage) or median (interquartile range). RESULTS: Among 1008 vascular specialist authors identified, 218 (22%) self-reported FCOI. Fifty-six physician authors had compensation reported to the Centers for Medicare and Medicaid Services by industry during the study period. Among those identified as recipients of industry compensation, 28 (50%) self-reported FCOI. Industry payments to the 56 authors totaled $11,139,987, with a median total payment of $18,827 (interquartile range, $152,084) per author. Food and beverage was the most frequently identified nature of payment (n = 8981 [74%]), promotional speaking involved the largest total amount of payments ($3,256,431), and royalty or license was the highest median payment ($51,431 [$72,215]). Physicians reporting FCOI received a total of $9,435,340 during the study period vs $1,706,647 for those who did not report any FCOI. Median total payments were higher among authors reporting FCOI vs not ($81,224 [$324,171] vs $9494 [$43,448]; P < .001). CONCLUSIONS: Nondisclosed author compensation from industry is relatively uncommon among highly cited peripheral artery disease research studies but may be associated with substantial payments. These results suggest that self-reported FCOI does not provide a comprehensive overview of industry compensation. Reporting all payments rather than only those deemed relevant by the author might provide a more complete and transparent report of potential FCOI, allowing independent assessment of relevance in interpreting study findings.
引用
- Bellomo TR, Hwang C, Spector-Bagdady K, et al. Industry compensation and self-reported financial conflicts of interest among authors of highly cited peripheral artery disease studies. J Vasc Surg. 2020. PMID: 31980241. doi:10.1016/j.jvs.2019.09.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。